In the first study, published January 29 in JAMA Network Open, a research team from Johns Hopkins University School of Medicine in Baltimore, led by Dr
If used for medical conditions, your insurance may cover peptide therapy
Phase 1b/2a results (published in The Lancet, 2025): - In 125 adults with overweight or obesity, the subcutaneous 20 mg dose achieved 22.0% absolute weight loss (23.9% placebo-adjusted)
CX: Resources, Formal analysis, Investigation, Writing original draft
Join my app, Simply Strong, for simple, at-home-friendly weight training and high-protein recipes that will feed the whole family
Right now, that molecule is Retatrutide